Monthly Archives: August 2016

Student News Bulletin

This week a study links increased nightly fasting to reduced risk of developing breast cancer, the possible protective effect of flavonoids naringin and rutin against short-and long-term memory defecits, and BANT members benefit from 50 per cent off tickets to The Sugar Reduction Summit on 22nd September.

Prolonged nightly fasting and breast cancer prognosis

Inspired by promising animal trails, a prospective study by The University of California published this year in JAMA Oncology revealed that women who fast for less than 13 hours a night might increase their risk of mortality from breast cancer. Data was used from 2413 women with early-stage breast cancer who participated in the Women’s Healthy Eating and Living study. The mortality rates and recurrences of breast cancer where compared in two groups of women: those who fasted for less than 13 hours, and those who fasted 13 hours or more. Women who fasted less than 13 hours had increased risk of breast cancer recurrence, while those who fasted for more than 13 hours had no increased risk of breast cancer or all-cause mortality. Interestingly, each two-hour increase in nightly fasting duration was linked to significantly reduced haemoglobin A12 levels and longer sleep. The mechanism suggested was based on improvements in glucoregulation and sleep. this may provide a simple strategy for reducing breast cancer risk. Read the paper here

The potential protective effect of naringin and rutin on memory

An animal study published earlier this year by Manipal University in India suggests that the flavonoids naringin and rutin exert protective cognitive effects. This dose-dependent outcome seem to result from the reversal of short- and long-term episodic memory deficits. Wistar rats were given naringin and rutin at two doses for 15 days before and during the trial. The animals were observed doing novel object recognition tasks (NORT) and were monitored for any change in locomotor ability. Animals given higher doses of the flavonoids showed significant improvements doing recognition and discrimination indices compared to control. The authors suggest part of the procognitive effect may result from interactions of the flavonoids with intracellular signalling affecting vascular function, synaptic plasticity and neurogenesis in addition to their antioxidant power. The active compounds in naringin and rutin are narinenin and quercetin. Read the paper here

The Sugar Reduction Summit: Industry, Regulation and Public Health – on Thursday 22 September 2016 at the Royal Society of Medicine

Those who took a particular interest in the Government’s strategy for tackling Childhood Obesity may want to consider registering for this event in September. It is the third annual Sugar Reduction Summit which includes talks from leading speakers and debates about the feasibility and ability of regulations, including advertising, EU changes to labelling and sugar tax. The day will also involve exploring the impact of voluntary measure and examining the role of sweeteners in reducing sugar dependency. The Summit starts at 8.55 am, finishes at 5.15 pm and costs £195 including 50% discount and lunch. View full details and register here cheap air max 97


Welcome to the August issue of BANT ENews, despite the summer holidays, we once again have a very full and informative issue this month. Our theme for August is eye health, with a particular focus via our Featured Article on Macular Degeneration. Satu Jackson provides us with an update from the BANT Council’s Quarterly Meeting in Director’s Corner and we have an update from our recent Regional Branch Meeting in Leeds.

View the BANT News

View the eblast

BANT August News Goes Live

Welcome to the August issue of BANT ENews, despite the summer holidays, we once again have a very full and informative issue this month. Our theme for August is eye health, with a particular focus via our Featured Article on Macular Degeneration. Satu Jackson provides us with an update from the BANT Council’s Quarterly Meeting in Director’s Corner and we have an update from our recent Regional Branch Meeting in Leeds. Access the BANT news here.


Nutrigenomics: How to Choose a Test for Your Client (3 CPD hrs)
Nutrigenomics: A Practitioner’s Perspective (4 CPD hrs)
Nutrigenomics: Bridging the Gap Between Practical & Theoretical (3 CPD hrs)

We are delighted to bring you the recorded presentations and slides from three BANT Regional Branch meetings that featured high quality speakers on the topic of Nutrigenomics at locations across the UK. The events were rated ‘excellent value’ by the majority of attendees.

View the eblast

BANT’s Response to the Government’s Childhood Obesity Strategy

BANT welcomes the Government’s plans for tackling Childhood Obesity and in particular the proposal for a levy on sugar for producers/importers. Obesity is a complex issue and the Government’s proposals will set the background for establishing the changes needed to engender a long-term cultural shift which allows healthy behaviour adaptations to an environment which offers so many opportunities for unhealthy indulgence either knowingly or in ignorance.  BANT will be considering what tools it can offer to help this public health drive.


– Ends –

Click here to download the PDF version of this response.



Daniel O’Shaughnessy
[email protected]
Tel: +44 7540  722307



The British Association for Applied Nutrition and Nutritional Therapy (BANT) is the professional body for Registered Nutritional Therapists. Its primary function is to assist its members in attaining the highest standards of integrity, knowledge, competence and professional practice, in order to protect the client’s interests; nutritional therapy and the registered nutritional therapist.

Nutritional therapy is the application of nutrition science in the promotion of health, peak performance and individual care. It is a progressive approach to health optimisation.  Registered Nutritional Therapists are recognised by the Professional Standards Authority to be as competent as other traditional healthcare providers.  It has been recognised that they can make a difference by working together with healthcare providers as part of multidisciplinary teams under NHS commissioning.

Student News Bulletin

This week new research highlights the importance of being a healthy weight at midlife and we explore the rich information available to us at BANT by looking at a piece on gluten sensitivity and the wealth of webinars available to us.

Brain Ageing Accelerated by 10 Years with Midlife Overweight or Obesity

A new study from the University of Cambridge was published in the journal Neurobiology of Aging, which revealed that middle-aged adults who were overweight had reduced white matter volume in the brain, compared with their lean counterparts.  The researchers conducted a cross-sectional study in which they analyzed data of 473 cognitively healthy adults aged 20-87.  Participants were classified as lean, overweight or obese based on their BMI.  Cerebral white and grey matter volume was assessed using MRI.  Middle-aged adults who were overweight or obese had a white matter volume that was comparable to those of lean adults who were 10 years older.  “The fact that we only saw these differences from middle age onwards raises the possibility that we may be particularly vulnerable at this age. It will also be important to find out whether these changes could be reversible with weight loss, which may well be the case.” Said Prof. Paul Fletcher. Read more.


Non-Coeliac Gluten Sensitivity

BANT (British Association for Applied Nutrition and Nutritional Therapy) explores the evidence for NCGS (non-cieliac gluten sensitivity) to provide clarification on gluten sensitivity terms and practices.  Read more.


Expand Your Knowledge

It’s the summer holidays so maybe now you’ve got time to catch up on any webinars you missed.  Check out the full list of student webinars here, which includes a fascinating instalment on skin ageing from BANT chair, Miguel Toribio-Mateas.

BANT members can also access recordings of previous events, including webinars on chronic fatigue from Niki Gratrix and on insulin resistance from Dr. David Morris.  View the full listings herenike air max 1

Studies Support that Non-Coeliac Gluten Sensitivity is very real for some: BANT Explains

With so much information about different types of diets and their effects available to everyone from a range of ‘experts’, from qualified healthcare professionals to celebrities with a large following, it is not surprising that there is much confusion about gluten free diets, why they are popular, what they do and whether you may benefit from them or not.

BANT (British Association for Applied Nutrition and Nutritional Therapy) has been carefully monitoring reports of the varying degrees of sensitivity to gluten experienced by thousands of people in the UK and beyond.  It seems it is not just members of the public who may be uncertain as to what the effects of following a specific diet may be.  Scientists at Monash University in Australia, (a world-leading research centre for gastroenterology,) published a study in the Journal of Human Nutrition and Dietetics.  Their aim was to determine the attitudes towards diet of Inflammatory Bowel Disease patients and their clinicians. The large majority of the patients involved (71%) assumed that changes to their diet would translate into changes to their symptoms. In contrast, Monash researchers found that more gastroenterologists (44%) than dietitians (17%) agreed with their patients in that diet was a factor impacting gastrointestinal symptoms.

BANT Registered Nutritional Therapists practice within a clinical framework that uses dietary interventions as main drivers for change in symptoms (both perceived and/or biochemically measurable).

BANT can clarify the following points on gluten sensitivity

  • Some recent features seem to have trivialised the severity of gastrointestinal and systemic symptoms experienced by many by labelling them as “lifestyle coeliacs” or “coeliac lite”.
  • The scientific evidence documenting the effects resulting from sensitivity to gluten has increased over the last 15 years and is now solid. This evidence informs clear guidelines on the differential diagnosis of coeliac disease versus other conditions such as non-coeliac gluten sensitivity (NCGS), both within the Irritable Bowel Disease spectrum.
  • From a clinical audit on BANT member clinics, BANT believes that many of those who report non-coeliac gastrointestinal symptoms may be experiencing NCGS in varying degrees of severity.
  • NCGS is defined by the exclusion of coeliac disease including negative coeliac blood tests and/or normal intestinal architecture and negative immunoglobulin (Ig)E-mediated allergy tests to wheat. Additionally, to meet criteria for NCGS, the clinical symptomatology of Irritable Bowel Syndrome (IBS)-type of symptoms has to improve after gluten withdrawal and worsen after the ingestion of gluten.
  • Symptoms of NCGS can include those typical of IBS, namely bloating, diarrhoea, abdominal pain (sometimes related to alternating diarrhoea and constipation), nausea and fatigue. Experience of NCGS can be highly individual. Some will experience all the symptoms and some may experience only one or two.
  • Factors mediating NCGS symptoms include loss of gastrointestinal mucosal integrity, possibly driven by inflammation triggered by an immune reaction to various proteins contained in gluten-containing foods.
  • Because NCGS is a relatively new condition there is still a lack of diagnostic tests that are both sensitive and specific. However, there is ample evidence that individuals with significant intestinal symptoms who have tried a gluten-free diet have experienced lessening of severity of the symptoms mentioned above.
  • There is also evidence to support testing a gluten-free diet in clinical practice in people with significant intestinal symptoms which could be assessed as fitting into a NCGS diagnosis (to be issued by a gastroenterologist), and which are not solely explained by the degree of intestinal inflammation. Thus, a gluten-free diet has the potential to be a safe and highly efficient therapeutic approach.
  • BANT believes that the argument that a gluten-free diet promotes the development of orthorexia is flawed. BANT understands that dietary advice provided by unqualified celebrities on social media is part of the socially prescribed perfectionism and attachment to appearance seen as characteristics in orthorexia, but there is no scientific evidence to support this claim. Indeed, a review of the literature on this argument in the databases PubMed, EMBASE, CINAHL and Cochrane retrieves zero results. As such, the correlation between the adoption of a gluten free diet and the development of orthorexia is just seen as an expert opinion, which counts as the lowest degree of evidence. Furthermore, BANT believes that to associate the development of a psychiatric disorder with a safe and therapeutically effective dietary intervention without any scientific evidence to support it is irresponsible and is seen as unfounded scaremongering.
  • One of the main reasons provided by those who propose that gluten-free diets are dangerous is the potential lack of dietary fibre that may result as an effect of this dietary change. BANT sees this as incongruous advice, considering the following:
    • There is ample dietary fibre in fruit and vegetables.
    • There is no evidence to suggest that those individuals who reduce or cut gluten out of their diets also reduce and/or cut out fruit and/or vegetables.
  • BANT is aware of the barriers to following a gluten-free diet, including product availability, cost and safety of gluten-free foods, as well as gluten cross-contamination.
  • BANT is acutely aware of the fact that self-reported measures, most often used as sources of data in studies that assess the effect of gluten-free diets, account for the possibility of unintentional gluten ingestion and overestimate adherence to diets. Additionally, some people who believe they are following a gluten-free diet are not readily able to correctly identify foods that are gluten-free, which suggests ongoing gluten consumption may be occurring, even among those who believe they are “strictly” adherent.
  • BANT Registered Nutritional Therapists follow a consultation process that puts the relationship between diet and gastrointestinal symptoms at its core, as illustrated in the BANT Consultation Process Poster. Anyone experiencing gastrointestinal symptoms such as bloating, diarrhoea, abdominal pain (sometimes related to alternating diarrhoea and constipation), nausea and fatigue would be advised to seek the advice of a BANT Registered Nutritional Therapist and gastroenterologist who can co-manage your case.
  • BANT welcomes the collection and analysis of patient-generated data on the association between gluten-free diets and orthorexia that contribute towards the creation of an evidence base on this subject and is happy to talk to organisations who would like to support this research exercise.


Grains containing glutenwheat (including wheat varieties like spelt, kamut, farro and durum, plus products like bulgar and semolina), barley, rye, triticale and oats* Gluten free grains – corn, millet, rice, sorghum.

Gluten free pseudo-cerealsamaranth, buckwheat, quinoa. These can be good substitutes to gluten-containing grains if you’re on a gluten free diet, but do rotate them so that your nutrient intake is varied.

*Gluten free oats are available


– Ends –

Click here to download the PDF version of this statement.



Daniel O’Shaughnessy

[email protected]

Tel: +44 7540  722307


The British Association for Applied Nutrition and Nutritional Therapy (BANT) is the professional body for Registered Nutritional Therapists. Its primary function is to assist its members in attaining the highest standards of integrity, knowledge, competence and professional practice, in order to protect the client’s interests; nutritional therapy and the registered nutritional therapist.



  • Barnes, M. A. & Caltabiano, M. L. (2016) The interrelationship between orthorexia nervosa, perfectionism, body image and attachment style. Eat Weight Disord. [Epub ahead of print]
  • Czaja-Bulsa, G. (2015) Non coeliac gluten sensitivity – A new disease with gluten intolerance. Clin Nutr, 34(2) pp. 189-94.
  • Dunn, T. M., Gibbs, J., Whitney, N. & Starosta, A. (2016) Prevalence of orthorexia nervosa is less than 1 %: data from a US sample. Eat Weight Disord. [Epub ahead of print]
  • Escudero-Hernandez, C., Pena, A. S. & Bernardo, D. (2016) Immunogenetic Pathogenesis of Celiac Disease and Non-celiac Gluten Sensitivity. Curr Gastroenterol Rep, 18(7) pp. 36.
  • Kabbani, T. A., Vanga, R. R., Leffler, D. A., Villafuerte-Galvez, J., Pallav, K., Hansen, J., Mukherjee, R., Dennis, M. & Kelly, C. P. (2014) Celiac disease or non-celiac gluten sensitivity? An approach to clinical differential diagnosis. Am J Gastroenterol, 109(5) pp. 741-6; quiz 47.
  • Herfarth, H. H., Martin, C. F., Sandler, R. S., Kappelman, M. D. & Long, M. D. (2014) Prevalence of a gluten-free diet and improvement of clinical symptoms in patients with inflammatory bowel diseases. Inflamm Bowel Dis, 20(7) pp. 1194-7.
  • Hollon, J., Puppa, E. L., Greenwald, B., Goldberg, E., Guerrerio, A. & Fasano, A. (2015) Effect of gliadin on permeability of intestinal biopsy explants from celiac disease patients and patients with non-celiac gluten sensitivity. Nutrients, 7(3) pp. 1565-76.
  • Holt, D. Q., Strauss, B. J. & Moore, G. T. (2016) Patients with inflammatory bowel disease and their treating clinicians have different views regarding diet. J Hum Nutr Diet,
  • Johanson, L. (2015) The Gluten-Free Frenzy: Fad or Fitting? Medsurg Nurs, 24(4) pp. 213-7.
  • Mansueto, P., Seidita, A., D’alcamo, A. & Carroccio, A. (2014) Non-celiac gluten sensitivity: literature review. J Am Coll Nutr, 33(1) pp. 39-54.
  • See, J. A., Kaukinen, K., Makharia, G. K., Gibson, P. R. & Murray, J. A. (2015) Practical insights into gluten-free diets. Nat Rev Gastroenterol Hepatol, 12(10) pp. 580-91.
  • Silvester, J. A., Weiten, D., Graff, L. A., Walker, J. R. & Duerksen, D. R. (2016) Is it gluten-free? Relationship between self-reported gluten-free diet adherence and knowledge of gluten content of foods. Nutrition, 32(7-8) pp. 777-83.
  • Thomas, L. E. (2013) How evidence-based medicine biases physicians against nutrition. Med Hypotheses, 81(6) pp. 1116-9.
  • Tursi, A. & Brandimarte, G. (2003) The symptomatic and histologic response to a gluten-free diet in patients with borderline enteropathy. J Clin Gastroenterol, 36(1) pp. 13-7.
  • Volta, U., Pinto-Sanchez, M. I., Boschetti, E., Caio, G. P., De Giorgio, R. & Verdu, E. F. (2016) Dietary triggers in irritable bowel syndrome: Is there a role for gluten. J Neurogastroenterol Motil [Epub ahead of print].

Student News Bulletin

This week an intriguing study looking in to the effect of resveratrol on Alzheimers, a study linking the diet of fathers to risk of developing breast cancer in daughters, and there are still spaces available at the CAM conference in November on stress and chronic inflammation.

Resveratrol may slow progression of Alzheimer’s 

The follow up to a study published in the journal Neurology last year has found that long-term resveratrol treatment in sufferers of mild to moderate Alzheimer’s seems to slow the progress of the brain disease. The findings were reported to the Alzheimer’s Association International Conference 2016 in Toronto this week.

Found in grapes, blueberries, raspberries, chocolate and red wine, the compound resveratrol is believed to be instrumental in the release of sirloins, as happens during caloric restriction known to reduce age-related diseases in animals.

This trial also discovered that in the participants taking resveratrol, the levels of matrix metalloproteinase-9 (MMP-9), an inflammatory protein involved in the breakdown of the blood-brain barrier, was reduced by 50 per cent. MMP-9 is reduced when sirtuin1 is activated.

In this way, it is thought that resveratrol may benefit individuals by restoring the integrity of the blood-brain barrier, preventing inflammatory proteins and molecules from entering the brain. Read more

A father’s high-fat diet may protect against breast cancer development in daughters

In this trial by the University of Sao Paulo, published in the journal of Breast Cancer Research, it was discovered that the daughters of male rats fed a diet high in animal fats were more likely to develop breast cancer.

60 male rats were fed a high fat diet based on lard or corn oil and compared to a control diet. Subsequently, their email offspring were fed a normal chow diet. Once the daughter rats reached 50 days old, mammary tumour growth was stimulated.

Tumour growth, the number of tumours, the length of time it took for tumours to start growing, and the volume of the growths were compared and used as indicators of breast cancer risk.

The team discovered that the daughters of the male rats that had been fed the high fat, corn-oil based diet (high in omega 6 polyunsaturated fatty acids) grew fewer tumours, showed reduced tumour growth, and the time it took for tumour growth to initiate was longer.

The researchers believe this may suggest that vegetable oil consumption in men may have a protective effect on daughters’ risk of breast cancer. Read more

November CAM conference spaces still available

Nutrition resolution: breaking the cycle of stress and chronic inflammation on Saturday 5th November 2016, 9.50-4.30pm.

£92 (10 per cent discount to students) includes the day’s talks, goody bag, 4.5 hours CPD accreditation, delicious 3-course gluten-free lunch, access to 17 exhibitors, and more. The internationally-renowned speakers include:

Dr Jolanta Opacka-Juffry, a neuroscientist with interest and expertise in experimental brain disorders, depression and effects of early life stress, particularly prenatal and early postnatal stress.

Lou Lebentz specialises in sugar and obesity addiction and has experience and understanding of the role of chronic stress in addictive behaviours.

Dr William Walsh has a wealth of experience with behavioural disorders, depression, anxiety, schizophrenia, ADHD, autism and Alzheimer’s, with a particular expertise with nutrient imbalances and how they alter brain chemistry.

CAM Conferences 2016 booking form


Summer Offer – Free* Histamine Genotype Report (RRP £39).
*Note that a 23andMe test result is required to run our reports. Offer available during August 2016.

Ingeneius reports provide personalised genotype analyses to help you to understand your clients’ health at the most fundamental level.

Nutrigenomics in Practice: Methylation Seminars:
17th September, London – £99 – use code BANT20
1st October, Bristol – £75 – use code BANT10

View the eblast